Paul Wachter

This profile gathers the share dealings of Paul Wachter across 3 companies, led by Adverum Biotechnologies, Inc., Time Warner Inc. and Virgin America Inc. In total, 45 filings cover trades dated from 15 December 2010 to 14 June 2018.

Both buying and selling appear: 3 purchases worth €527k, against 20 sales worth €1.1M. On balance, insiders were net sellers of €526k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 10 share grants and 8 option exercises.

Half of the purchases are above €144k and half below.

The newest entry dates from 18 June 2018: a transaction, in Time Warner Inc. The last purchase on record was published on 13 November 2014, which is 4,378 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.